Press Releases Sanofi Bulgaria S.E.

Equities

SNW

FR0000120578

End-of-day quote Bulgaria S.E. Other stock markets 18:00:00 2024-05-26 EDT			5-day change	1st Jan Change
89.4 ^EUR	+1.61%		-.--%	+5.96%

06-27	CAC40: caution prevails ahead of crucial deadlines	CF
06-27	CAC40: consolidates solo, OAT/Bund spread widens to 81Pb	CF

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sanofi - Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM	06-27	AQ
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM	06-26	GL
Press Release: Availability of the Q2 2024 Aide-mémoire	06-25	GL
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee	06-21	GL
List of Companies That Allegedly Left Nigeria Under Tinubu's Presidency Is Not Accurate	06-21	AQ
Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran	06-21	GL
Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa	06-20	GL
INNATE PHARMA SHARES UPDATED RESULTS FROM THE SANOFI DEVELOPED BLOOD CANCER PHASE SAR443579/IPH6101 TRIAL	06-18	AQ
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mai 2024	06-12	PU
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	06-11	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development	06-11	AQ
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer	06-07	AQ
Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development	06-06	AQ
SANOFI : L’AMMC vise le prospectus relatif à l’augmentation de capital du groupe « SANOFI » réservée aux salariés du groupe	06-04	PU
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3	06-03	GL
Sanofi - Dupixent recommended for EU approval by the CHMP to treat patients with COPD	06-03	AQ
Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan	05-31	GL
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD	05-31	GL
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation	05-31	GL
Largest vaccine production plant in Canada opens in Toronto	05-30	AQ